| Officer | Age | In this role | Joined | Pay | Source |
|---|---|---|---|---|---|
|
Ronen Twito
Also a director
Executive Chairman & Chief Executive Officer
|
51 | Not stated | Not stated | Not reported | |
|
Omri Hagai
Chief Financial Officer
|
40 |
Since 2025
1 year
|
Not stated | Not reported | |
|
Michel Revel
Also a director
Chief Scientific Officer and Director
|
87 | Not stated | Not stated | Not reported | |
|
Alexander C. Zwyer
Also a director
Chief Business Officer and Director
|
57 | Not stated | Not stated | Not reported | |
|
Kfir Molakandov
Vice President of Research and Development
|
48 |
Since 2025
1 year
|
Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. NewcelX AG has not filed one with the SEC.
Loading...
